Immatics (IMTX) Interest & Investment Income (2019 - 2025)
Immatics (IMTX) reported Interest & Investment Income of $4.5 million for Q4 2025, down 83.51% on a YoY basis from $27.0 million in Q4 2024, and down 10.22% sequentially from $5.0 million in Q3 2025.
Immatics (IMTX) Interest & Investment Income (2019 - 2025) Analysis & Trends
Immatics (IMTX) has 7 years of Interest & Investment Income data on file, last reported at $4.5 million in Q4 2025.
- For the quarter ending Q4 2025, Interest & Investment Income fell 83.51% year-over-year to $4.5 million; the trailing twelve-month figure through Dec 2025 stood at $21.0 million (down 62.65% YoY), and the FY2025 full-year result was $20.9 million, down 56.09% from the prior year.
- Interest & Investment Income fell to $4.5 million in Q4 2025, from $5.0 million in the prior quarter.
- In the past five years, Interest & Investment Income ranged from a high of $27.0 million in Q4 2024 to a low of -$7.3 million in Q4 2022.
- A 5-year average of $5.6 million and a median of $4.7 million in 2025 frame the typical range for Interest & Investment Income.
- Across the five-year window, Interest & Investment Income plunged 634.44% in 2022 and soared 4557.13% in 2024, its largest moves.
- Tracing IMTX's Interest & Investment Income over 5 years: stood at $1.4 million in 2021, then plunged by 634.44% to -$7.3 million in 2022, then surged by 91.74% to -$606830.1 in 2023, then surged by 4557.13% to $27.0 million in 2024, then sank by 83.51% to $4.5 million in 2025.
- Business Quant data shows IMTX's Interest & Investment Income at $4.5 million in Q4 2025, $5.0 million in Q3 2025, and $5.0 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 27.66 Mn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 114.80 Mn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | -65.80 Mn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | 44.00 Mn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | 19.51 Mn |
| 10 | Immatics | 1.11 Bn | 1.11 Bn | - | 4.46 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 4.46 Mn |
| Sep 30, 2025 | 4.97 Mn |
| Jun 30, 2025 | 5.00 Mn |
| Mar 31, 2025 | 6.59 Mn |
| Dec 31, 2024 | 27.05 Mn |
| Sep 30, 2024 | 6.47 Mn |
| Jun 30, 2024 | 10.41 Mn |
| Mar 31, 2024 | 12.36 Mn |
| Dec 31, 2023 | -606,830.11 |
| Sep 30, 2023 | 10.61 Mn |
| Jun 30, 2023 | 4.31 Mn |
| Mar 31, 2023 | 3.00 Mn |
| Dec 31, 2022 | -7.34 Mn |
| Sep 30, 2022 | 7.90 Mn |
| Jun 30, 2022 | 7.49 Mn |
| Mar 31, 2022 | 1.97 Mn |
| Dec 31, 2021 | 1.37 Mn |
| Sep 30, 2021 | 1.68 Mn |
| Jun 30, 2021 | 256,509.82 |
| Mar 31, 2021 | 4.18 Mn |